Results 191 to 200 of about 6,940,670 (314)

Long-term treatment with ALK inhibitors for postoperative recurrence of ALK-rearranged lung cancer

, 2022
Ken Kodama, Yukio Kimura, Toru Momozane, Kaichi Sigetsu, Masashi Takeda, Hiroki Kishima   +5 more
openalex   +2 more sources

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

New England Journal of Medicine, 2010
E. Kwak, Y. Bang, D. Camidge, A. Shaw, B. Solomon, Robert G. Maki, Sai-Hong Ignatius Ou, B. Dezube, P. Jänne, Daniel, B. Costa, M. Varella-Garcia, W. Kim, Thomas J. Lynch, P. Fidias, Hannah Stubbs, J. Engelman, V. Lecia, Sequist, Weiwei Tan, L. Gandhi, M. Mino‐Kenudson, Greg C. Wei, S. M. Shreeve, M. Ratain, Jeffrey, Settleman, James G. Christensen, D. Haber, K. Wilner, R. Salgia, Geoffrey I. Shapiro, J. Clark, A. Iafrate   +33 more
semanticscholar   +1 more source

Engineering tandem VHHs to target different epitopes to enhance antibody‐dependent cell‐mediated cytotoxicity

FEBS Open Bio, EarlyView.
Tandem VHH targeting distinct EGFR epitopes were engineered into a monovalent bispecific antibody (7D12‐EGA1‐Fc) with more potent ADCC without increasing affinity to EGFR. Structural modeling of 7D12‐EGA1‐Fc showed cross‐linking of separate EGFR domains to enhance CD16a engagement on NK cells.
Yuqiang Xu, Hao Jiang, Limin Chen, Fulai Zhou, Ying Jin, Mark L. Chiu   +5 more
wiley   +1 more source

Microplastics Exposure Impact on Lung Cancer-Literature Review. [PDF]

Cancers (Basel)
Sychowski G, Romanowicz H, Cieślik-Wolski B, Wojciechowska-Durczyńska K, Smolarz B.   +4 more
europepmc   +1 more source

A Bayesian hierarchical approach to account for left-censored and missing radiation doses prone to classical measurement error when analyzing lung cancer mortality due to γ-ray exposure in the French cohort of uranium miners

, 2020
Marion Belloni, Chantal Guihenneuc‐Jouyaux, Estelle Rage, Sophie Ancelet   +3 more
openalex   +2 more sources

Real-World Use of Systemic Anticancer Treatment by Histology and Line of Therapy in U.S. Medicare Patients With Advanced Non-Small Cell Lung Cancer [PDF]

, 2014
Lucinda Orsini, Beata Korytowsky, Allison Petrilla, Juan P. Wisnivesky, Christopher Craver, Mark Salvati, D. Hines, Prina Donga, CM Blanchette, Rolin L. Wade, JR Penrod   +10 more
openalex   +1 more source

FGFR Like1 drives esophageal cancer progression via EMT, PI3K/Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis

FEBS Open Bio, EarlyView.
Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava, Anoop Saraya, Deepak Gunjan, Rinu Sharma   +3 more
wiley   +1 more source

Correction to "Second Primary Lung Cancer Associated With Family History of Lung Cancer". [PDF]

Cancer Med
europepmc   +1 more source

Hydrogel Formulations to Investigate Lung Cancer Mechanism. [PDF]

Thorac Res Pract
Saskara A, Arslan Y, Yesil-Celiktas O.
europepmc   +1 more source

Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer [PDF]

Feng Cai, Zhengjun Guo, Guoyu Wang, Feng Luo, Yang Yang, Min Lv, Jie He, Zhou Xiu, Dan Tang, Xiao‐Hui Bao, XiaoYue Zhang, ZhenZhou Yang, Zhi X. Chen   +12 more
openalex   +1 more source